SCHEMBL96188

SCHEMBL96188

CCOC(=O)CCCCO

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
CYP4F2 P78329 4/20 0.51
CYP4A11 Q02928 4/20 0.51
ALDH1A1 P00352 3/20 0.50
GAA P10253 2/20 0.50
ALOX15 P16050 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
MGAM O43451 1/20 0.50
SI P14410 1/20 0.50
MGAM2 Q2M2H8 1/20 0.50
DGKA P23743 1/20 0.50
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
NR1I2 O75469 1/20 0.48
PGR P06401 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
PTGS2 P35354 1/20 0.48
PDE4D Q08499 1/20 0.48
TRPA1 O75762 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3288792 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL3503524 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL3503495 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL1896403 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL3501621 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL1265010 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL1060504 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL3503187 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL2559740 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL247007 0.98 CYP1A2 (0.59) CYP1A2CYP4F2CYP4A11ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 450 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250325970-A1 CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF UNIV SICHUAN (CN) 2025-10-23 US claimed
EP-4527872-A1 CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan University (CN) 2025-03-26 EP claimed
CN-117903582-A Full-biodegradation polylactic acid composite material and application thereof 上海汉禾生物新材料科技有限公司 2024-04-19 CN claimed
WO-2023231524-A1 CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF 四川大学 2023-12-07 WO claimed
CN-114805776-A Catalyst for polyester depolymerization or cyclic ester synthesis, preparation method and application thereof 四川大学 2022-07-29 CN claimed
CN-106188527-A The process for purification of PEKK crude product 山东凯盛新材料股份有限公司 2016-12-07 CN claimed
CN-105885033-A Process for refining poly(ether-ketone-ketone) crude product 山东凯盛新材料股份有限公司 2016-08-24 CN claimed
US-20070179298-A1 Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds NOVARTIS AG (CH) 2007-08-02 US claimed
JP-2007506661-A 2007-03-22 JP claimed
US-20070037846-A1 Pyrazolidinedione derivatives ACTELION PHARMACEUTICALS, LTD. (CH) 2007-02-15 US claimed
EP-1638540-A2 PYRAZOLIDINEDIONE DERIVATIVES AND THEIR USE AS PLATELET AGGREGATION INHIBITORS Actelion Pharmaceuticals Ltd. (CH) 2006-03-29 EP claimed
EP-1599440-A2 CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS Novartis AG (CH) 2005-11-30 EP claimed
WO-2005000281-A2 PYRAZOLIDINEDIONE DERIVATIVES AND THEIR USE AS PLATELET AGGREGATION INHIBITORS ACTELION PHARMACEUTICALS LTD. (CH) 2005-01-06 WO claimed
WO-2004076053-A2 CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS NOVARTIS AG (CH) 2004-09-10 WO claimed
US-20250325970-A1 CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF UNIV SICHUAN (CN) 2025-10-23 US disclosed
CN-119161338-B Tetrahydropyridine derivatives useful as muscarinic receptor agonists and their pharmaceutical use 嘉兴安帝康生物科技有限公司 2025-06-17 CN disclosed
EP-4527872-A1 CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan University (CN) 2025-03-26 EP disclosed
US-4064139-A TRANQUILIZERS, ANTICONVULSANTS, MUSCLE RELAXANTS, ANTI-PARKINSON'S DISEASE MERCK & CO., INC. (US) 1977-12-20 US disclosed
US-4020165-A Control of acarids using certain benzothiazoles or benzothiazolines UNIROYAL INC. (US) 1977-04-26 US disclosed
US-3974287-A MITICIDES UNIROYAL INC. (US) 1976-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070037846-A1 Pyrazolidinedione derivatives P2RY1, P2RY4, P2RY2 CYP1A2 456/4885CYP4F2 2301/4885CYP4A11 1452/4885
US-20250325970-A1 CATALYST FOR POLYESTER DEPOLYMERIZATION OR CYCLIC ESTER SYNTHESIS, PREPARATION METHOD THEREFOR AND USE THEREOF NOTUM, WEE1, FAR1 CYP1A2 1249/4885CYP4F2 299/4885CYP4A11 12/4885
US-20070179298-A1 Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds HAO1, LMNA, HAO2 CYP1A2 755/4885CYP4F2 989/4885CYP4A11 925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.